Meningitis Due to Vancomycin-Resistant Enterococcus faecium Successfully Treated with Combined Intravenous and Intraventricular Chloramphenicol
Open Access
- 1 July 2005
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 43 (7), 3578-3579
- https://doi.org/10.1128/jcm.43.7.3578-3579.2005
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Pathogens resistant to antimicrobial agents: Epidemiology, molecular mechanisms, and clinical managementInfectious Disease Clinics of North America, 2004
- In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptidesJournal of Antimicrobial Chemotherapy, 2003
- Initial Quality Control Evaluations for Susceptibility Testing of Dalbavancin (BI397), an Investigational Glycopeptide with Potent Gram-Positive ActivityJournal of Clinical Microbiology, 2003
- Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristinClinical Neurology and Neurosurgery, 2002
- Successful Treatment of Vancomycin-resistant Enterococcus faecium Meningitis with Linezolid: Case Report and Literature ReviewScandinavian Journal of Infectious Diseases, 2001
- Activity of LY333328 Combined with Gentamicin In Vitro and in Rabbit Experimental Endocarditis Due to Vancomycin-Susceptible or -Resistant Enterococcus faecalisAntimicrobial Agents and Chemotherapy, 2000
- Intrathecal use of colistin.2000
- National Nosocomial Infections Surveillance (NNIS) Report, data summary from October 1986–April 1996, issued May 1996American Journal of Infection Control, 1996
- Chloramphenicol disposition in infants and childrenThe Journal of Pediatrics, 1979
- Intraventricular ChloramphenicolPediatric Neurosurgery, 1978